Visium Asset Management
View Older Stories View More Recent Stories
-
10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions
-
Form NT 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
10x Genomics First to Market With Product to Simultaneously Capture Epigenome and Transcriptome
-
10x Genomics First to Market With Product to Simultaneously Capture Epigenome and Transcriptome
-
Digital Colony Appoints Matty Yohannan as Chief of Staff
-
10X Genomics (TXG) PT Raised to $100 at Cowen After Revenue Beats Despite Research Lab Closures
-
10x Genomics Reports Second Quarter 2020 Financial Results
-
10x Genomics Reports Second Quarter 2020 Financial Results
-
Amid pandemic, wealthy U.S. families approved for government loans
-
Form 10-Q VISIUM TECHNOLOGIES, For: Mar 31
-
10x Genomics Selects First 45 Members for Visium Clinical Translational Research Network
-
10x Genomics Selects First 45 Members for Visium Clinical Translational Research Network
-
Form 8-K VISIUM TECHNOLOGIES, For: May 14
-
Form 8-K VISIUM TECHNOLOGIES, For: May 07
-
Visium Technologies Obtains Exlusive License Rights To Its Cybersecurity Technology
-
VISIUM TECHNOLOGIES SELECTS PREMIER VENDOR TO DEVELOP SOFTWARE AS A SERVICE PLATFORM FOR CYGRAPH®
-
VISIUM TECHNOLOGIES SELECTS PREMIER VENDOR TO DEVELOP SOFTWARE AS A SERVICE PLATFORM FOR CYGRAPH®
-
VISIUM TECHNOLOGIES LEVERAGES AMAZON WEB SERVICES TO OFFER ITS CYGRAPH® CYBERSECURITY SOLUTION
-
VISIUM TECHNOLOGIES LEVERAGES AMAZON WEB SERVICES TO OFFER ITS CYGRAPH® CYBERSECURITY SOLUTION
-
Form 4 VISIUM TECHNOLOGIES, For: Mar 17 Filed by: Lucky Mark Burdon
-
Ipsidy Announces Phil Broenniman to Join Board
-
Ipsidy Announces Phil Broenniman to Join Board
-
INVESTOR UPDATE FOR VISIUM TECHNOLOGIES, INC.
-
INVESTOR UPDATE FOR VISIUM TECHNOLOGIES, INC.
-
Form 4 VISIUM TECHNOLOGIES, For: Mar 05 Filed by: Lucky Mark Burdon
-
10x Genomics Debuts Range of New Products at AGBT
-
10x Genomics Debuts Range of New Products at AGBT
-
10x Genomics (TXG) Tops Q4 EPS by 4c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus
-
10x Genomics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Revenue Guidance
-
10x Genomics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Revenue Guidance
-
Form 10-Q VISIUM TECHNOLOGIES, For: Dec 31
-
10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution
-
10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution
-
Form 4 VISIUM TECHNOLOGIES, For: Aug 21 Filed by: Lucky Mark Burdon
-
VISIUM TECHNOLOGIES ACHIEVES NUTANIX AHV SECURITY DESIGNATION
-
VISIUM TECHNOLOGIES ACHIEVES NUTANIX AHV SECURITY DESIGNATION
-
Form 10-Q VISIUM TECHNOLOGIES, For: Sep 30
-
10x Genomics Reports Third Quarter 2019 Financial Results and Provides 2019 Revenue Guidance
-
10x Genomics Reports Third Quarter 2019 Financial Results and Provides 2019 Revenue Guidance
-
Form 8-K VISIUM TECHNOLOGIES, For: Oct 24
-
VISIUM TECHNOLOGIES UNVEILS CYGRAPH AT .NEXT CONFERENCE
-
VISIUM TECHNOLOGIES UNVEILS CYGRAPH AT .NEXT CONFERENCE
-
VISIUM TECHNOLOGIES TO ATTEND THE 2019 NUTANIX .NEXT EUROPE CONFERENCE
-
VISIUM TECHNOLOGIES TO ATTEND THE 2019 NUTANIX .NEXT EUROPE CONFERENCE
-
Form 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
VISIUM TECHNOLOGIES ANNOUNCES MAJOR ENHANCEMENTS TO COMMERCIALIZE ITS CYBERSECURITY TECHNOLOGY
-
VISIUM TECHNOLOGIES ANNOUNCES MAJOR ENHANCEMENTS TO COMMERCIALIZE ITS CYBERSECURITY TECHNOLOGY
-
Payer Compass Announces Appointments of Chief Financial Officer and Chief Revenue Officer
-
Form 10-Q/A VISIUM TECHNOLOGIES, For: Mar 31
-
Form 10-Q VISIUM TECHNOLOGIES, For: Mar 31

